For months at Erlanger, Sentri7 failed to raise alarms, overlooking missing drugs and other “inconsistencies” that “should have been flagged,” the nursing board’s order states.
Bemotrizinol is a newly approved over-the-counter sunscreen active ingredient that offers broad-spectrum protection with low systemic absorption.
The phase 3 KEYNOTE-D46/EVOKE-03 study evaluated sacituzumab govitecan/pembrolizumab vs pembrolizumab in untreated PD-L1-high metastatic NSCLC.
Phase 3 ISLEND-1 and ISLEND-2 trials met primary endpoints at week 48, showing a novel, once-weekly oral single-tablet regimen is noninferior to daily B/F/TAF or standard ART.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results